Mind Medicine (MindMed) Stock (NASDAQ:MNMD)

USA |NASDAQ |USD

Price
$1.91
Change
-3.54%
Today's Range
$1.91 - $2.15
52-Week Range
$1.66 - $5.77
Market Cap
$827.41M
Volume
4.23M

About Mind Medicine (Mindmed) (NASDAQ:MNMD)

(NASDAQ:MNMD)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Show more

MNMD Stock Price

Statistics Highlights (NASDAQ:MNMD)

Shares Outstanding 420.74M Beta -
Public Float 364.88M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 16.90% Ex-Dividend Date
Held by Institutions 11.74% IPO Date Mar 3, 2020

MNMD Financial Summary

|
Dec 20 Dec 19
Revenue $ $
EBITDA $ $
Net Income $-35.34M $-1.23M
Total Assets $85.64M $11.96M
Total Cash $ $
Total Debt $ $
Sep 21 Jun 21 Mar 21
Revenue $0.00 $0.00 $0.00
EBITDA $-20.01M $-33.21M $-13.83M
Net Income $-23.14M $-36.30M $-14.85M
Total Assets $178.58M $193.87M $200.79M
Total Cash $145.92M $157.10M $159.99M
Total Debt $ $ $

(NASDAQ:MNMD) Stock Price FAQs

What is today's stock price of Mind Medicine (Mindmed) (NASDAQ:MNMD)?

  • The current stock price of Mind Medicine (Mindmed) (NASDAQ:MNMD) is $1.91.
  • Today MNMD stock price opened at $2.04 after previous close of $1.98.
  • During the day, Mind Medicine (Mindmed) stock quote has varied from a low of $1.91 to a high of $2.15.

What is Mind Medicine (Mindmed)'s 52-week change?

  • MNMD 52-week high stock quote is $5.77, which is 202.10% above the current share price.
  • The Mind Medicine (Mindmed) (NASDAQ:MNMD) 52-week low stock price is $1.66, which is 13.10% below the current share price.

Mind Medicine (Mindmed) (NASDAQ:MNMD) FAQ

How Much is Mind medicine (mindmed) Worth?

Mind medicine (mindmed)'s worth today based on market capitalisation is $827.41M

How much money does Mind medicine (mindmed) make?

Last quarter (ended on September 30 ,2021) Mind medicine (mindmed) generated a net income of $-23.14M, representing a 62.52% decrease compared to the same quarter a year before (ended on September 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Mind medicine (mindmed) generated a net income of $-35.34M, representing a 2783.11% increase compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Mind medicine (mindmed)'s “Financials” Section

How much dividend does Mind medicine (mindmed) Pay?

The current annualized dividend payout for MNMD stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Mind medicine (mindmed)'s "Dividend" Section

What were Mind medicine (mindmed)’s last Earnings results?

For the last quarterly earnings period (ended on September 30, 2021) MNMD reported $-0.06 EPS for the quarter, missing the average analysts’ forecasts of $-0.04 EPS by $-0.03 (-71.43%).
View More Details on Mind medicine (mindmed)'s 'Earnings' Section

When is the next earnings date for Mind medicine (mindmed) (NASDAQ:MNMD)?

Mind medicine (mindmed) is expected to report earnings on March 28 ,2022.
View More Details on Mind medicine (mindmed)'s 'Earnings' Section

What is Mind medicine (mindmed)’s Price to Earning (PE) ratio?

MNMD stock also has a Price to Sales (P/S) ratio of 0.00.

What is the Mind medicine (mindmed)'s ticker?

Mind medicine (mindmed) trades on the NASDAQ stock market in USA under the ticker symbol "MNMD". Mind medicine (mindmed)’s stock symbol can also be displayed as "NASDAQ:MNMD".

When did MNMD go public?

Mind medicine (mindmed) completed its initial public offering (IPO) on March 03 ,2020.

Who are the owners of Mind medicine (mindmed)?

Mind medicine (mindmed) (NASDAQ:MNMD) is owned by 11.73% institutional shareholders and by 16.90% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "BlackRock Inc", "State Street Corporation" and "Geode Capital Management, LLC", representing 6.21% of Mind medicine (mindmed)’s total shares outstanding.
Explore More Details on Mind medicine (mindmed)'s “Ownership” Section

Who are the key executives of Mind medicine (mindmed) (MNMD)?

Mind medicine (mindmed)'s key executive team includes the following managers:

  • Dr. Miriam Halperin Wernli Ph.D., Exec. Pres & Director (NA)
  • Mr. Jamon Alexander Rahn, Co-Founder & Advisor (NA)
  • Dr. Scott M. Freeman, Co-Founder & Clinical Advisor (1957)
  • Mr. David Dean Guebert CA, CPA, Chief Financial Officer (NA)
  • Mr. Robert Barrow, Chief Exec. Officer (NA)
  • Mr. Leonard Latchman, Co-founder (NA)
  • Mr. Jakub Klimes M.Sc., VP of Global Operations (NA)
  • Ms. Carrie Liao CPA, CGMA, VP of Corp. Controller & Accounting Principal (NA)
  • Mr. Bradford Cross, Chief Technology Officer (NA)
  • Dr. Donald R. Gehlert Ph.D., Chief Scientific Officer & Member of Scientific Advisory Board (NA)

What is Mind medicine (mindmed)’s Sector & Industry Classification?

Mind medicine (mindmed) (NASDAQ:MNMD) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Mind medicine (mindmed)?

Currently the number of employees working for Mind medicine (mindmed) is 22.

Where are Mind medicine (mindmed)'s Headquarters?

Mind medicine (mindmed) (NASDAQ:MNMD) is headquartered in NY, United States.

What are Mind medicine (mindmed)'s Address and Phone Number?

Mind medicine (mindmed)’s mailing address is One World Trade Center, New York, NY, United States, 10007.
The company’s phone number is None.

What is the official website for Mind medicine (mindmed)?

Mind medicine (mindmed)’s official website is http://www.mindmed.co